Health

Diarrhea-Causing 'Superbug' on the Rise, CDC Says. Should You Be Worried?

A dangerous and potentially deadly intestinal infection is on the rise in the United States, according to a new report from the Centers for Disease Control and Prevention (CDC). Clostridioides difficile, often referred to as C. diff, is a bacteria that can cause severe and recurring diarrhea - and it's becoming increasingly resistant to common antibiotics used to treat it.

Context

C. diff infections have long been a problem in healthcare settings, where the bacteria can spread rapidly between patients. However, the CDC now warns that C. diff is becoming more prevalent in the general community as well. In 2017, there were an estimated 223,900 infections and 12,800 deaths associated with C. diff in the United States alone. This represents a concerning rise from previous years, highlighting the need for greater awareness and action to combat this growing public health threat.

What Makes C. diff a 'Superbug'?

C. diff is considered a 'superbug' because it is becoming increasingly resistant to many of the antibiotics commonly used to treat it. **This antimicrobial resistance makes the infection much harder to eliminate, leading to more severe symptoms, longer hospital stays, and higher rates of complications and death.** The CDC reports that **over 35% of C. diff infections in the U.S. are now caused by drug-resistant strains**. This is a significant jump from just a decade ago, when only about 10-15% of cases involved resistant bacteria. Prolonged or improper use of antibiotics is a major driver of this resistance. When antibiotics kill off beneficial gut bacteria, it can allow C. diff to rapidly multiply and take over. The bacteria then evolve to survive subsequent antibiotic treatments, creating a vicious cycle.

Symptoms and Risk Factors

The primary symptom of a C. diff infection is **severe, watery diarrhea** that can occur several times per day. Other common symptoms include: - Abdominal pain and cramping - Fever - Loss of appetite - Nausea C. diff infections pose the greatest risk for **older adults**, especially those who have recently taken antibiotics or been hospitalized. People with weakened immune systems, such as those undergoing chemotherapy or with inflammatory bowel disease, are also at higher risk. While C. diff is typically treatable with antibiotics, some patients experience recurring infections that can be extremely difficult to resolve. This highlights the urgent need to address the growing threat of antibiotic resistance.

"C. diff is an urgent public health threat that requires immediate action," says Dr. Alison Arwady, Commissioner of the Chicago Department of Public Health. "We must work to improve antibiotic stewardship, enhance infection control measures, and educate the public on the dangers of this growing superbug."

Strategic Outlook

The rise of drug-resistant Clostridioides difficile, or C. diff, is a concerning development that demands greater awareness and proactive measures. This dangerous intestinal bacteria can cause severe, recurrent diarrhea and is becoming increasingly resistant to the antibiotics used to treat it. While the elderly and immunocompromised are most at risk, C. diff poses a threat to the general public as well. Curbing the spread of this superbug will require a multi-pronged approach involving healthcare providers, public health authorities, and engaged citizens. [RELATED: TrendWire article on antibiotic resistance]